Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
  1. 2021
  2. Published

    Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

    Lindström, U., Glintborg, B., Di Giuseppe, D., Schjødt Jørgensen, T., Gudbjornsson, B., Lederballe Grøn, K., Aarrestad Provan, S., Michelsen, B., Lund Hetland, M., Wallman, J. K., Nordström, D., Trokovic, N., Love, T. J., Krogh, N. S., Askling, J., Jacobsson, L. T. H. & Kristensen, L. E., 2 Aug 2021, In: Rheumatology (Oxford, England). 60, 8, p. 3635-3645 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. E-pub ahead of print

    One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis

    Glintborg, B., Lindstrom, U., De Giuseppe, D., Provan, S. A., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Wallman, J., Aaltonen, K., Hokkanen, A-M., Nordström, D., Jørgensen, T. S., Hansen, R. L., Jon Geirsson, A., Grøn, K., Krogh, N. S., Askling, J., Kristensen, L. E., Jacobsson, L. & DANBIO (Denmark), ARTIS/SRQ (Sweden), ICEBIO (Iceland), ROB-FIN (Finland), NOR-DMARD (Norway) registries, 2021, (E-pub ahead of print) In: Arthritis Care & Research.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2020
  5. Published

    Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

    Hetland, M. L., Haavardsholm, E. A., Rudin, A., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Lampa, J., Hørslev-Petersen, K., Uhlig, T., Grondal, G., Østergaard, M., Heiberg, M. S., Twisk, J., Lend, K., Krabbe, S., Hyldstrup, L. H., Lindqvist, J., Hultgård Ekwall, A-K., Grøn, K. L., Kapetanovic, M., Faustini, F., Tuompo, R., Lorenzen, T., Cagnotto, G., Baecklund, E., Hendricks, O., Vedder, D., Sokka-Isler, T., Husmark, T., Ljoså, M-K. A., Brodin, E., Ellingsen, T., Söderbergh, A., Rizk, M., Olsson, Å. R., Larsson, P., Uhrenholt, L., Just, S. A., Stevens, D. J., Laurberg, T. B., Bakland, G., Olsen, I. C., van Vollenhoven, R. & NORD-STAR study group, 2020, In: BMJ. 371, p. m4328

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL

    Hetland, M. L., Haavardsholm, EA., Rudin, A., Nordstrom, D., Nurmohamed, M., Gudbjornsson, B., Lampa, J., Horslev-Petersen, K., Uhlig, T., Grondal, G., Østergaard, M., Heiberg, M., Twisk, J., Krabbe, S., Lend, K., Olsen, I., Lindqvist, J., Ekwall, AKH., Grøn, K. L., Kapetanovic, C., Faustini, F., Tuompo, R., Lorenzen, T., Cagnotto, G., Baecklund, E., Hendricks, O., Vedder, D., Sokka-Isler, T., Husmark, T., Ljosa, MKA., Brodin, E., Ellingsen, T., Soderbergh, A., Rizk, M., Reckner, A., Larsson, P., Uhrenholt, L., Just, SA., Stevens, D., Laurberg, TB., Bakland, G. & Van Vollenhoven, R., 2020, In: Annals of the Rheumatic Diseases. 79, Suppl. 1, p. 13-14 2 p., OP0018.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  7. Published

    COMPARISON OF TREATMENT RETENTION OF SECUKINUMAB AND TNF-INHIBITORS IN PSORIATIC ARTHRITIS. OBSERVATIONAL DATA FROM A NORDIC COLLABORATION

    Lindstrom, U., Glintborg, B., Di Giuseppe, D., Jorgensen, TS., Gudbjornsson, B., Grøn, K. L., Provan, SA., Michelsen, B., Hetland, M. L., Wallman, JK., Nordstrom, D., Trokovic, N., Love, T., Krogh, NS., Askling, J., Jacobsson, LTH. & Kristensen, LE., 2020, In: Annals of the Rheumatic Diseases. 79, Suppl. 1, p. 431-432 2 p., THU0394.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES

    Glintborg, B., Lindstrom, U., Di Giuseppe, D., Provan, SA., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Wallman, JK., Aaltonen, K., Hokkanen, AM., Jorgensen, TS., Hansen, RL., Geirsson, AJ., Grøn, K. L., Krogh, NS., Askling, J., Kristensen, LE. & Jacobsson, LTH., 2020, In: Annals of the Rheumatic Diseases. 79, Suppl. 1, p. 724-725 2 p., FRI0275.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  9. Published

    Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study

    Grøn, K. L., Glintborg, B., Nørgaard, M., Mehnert, F., Østergaard, M., Dreyer, L., Krogh, N. S. & Hetland, M. L., 2020, In: Rheumatology (Oxford, England). 59, 8, p. 1949-1956 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. 2019
  11. Published
  12. Published

    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J., Hetland, M. L. & ARTIS Study Group, Mar 2019, In: Annals of the Rheumatic Diseases. 78, 3, p. 320-327 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial

    Hetland, M. L., Haavardsholm, E. A., Rudin, A., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Lampa, J., Hørslev-Petersen, K., Uhlig, T., Grondal, G., Østergaard, M., Heiberg, M., Twisk, J., Lend, K., Krabbe, S., Lindqvist, J., Ekwall, A-K., Grøn, K. L., Kapetanovic, M., Faustini, F., Tuompo, R., Lorenzen, T., Cagnotto, G., Baecklund, E., Hendricks, O., Vedder, D., Sokka-isler, T., Husmark, T., Ljoså, M-K. A., Brodin, E., Ellingsen, T., Söderbergh, E., Rizk, M., Reckner, Å., Uhrenholt, L., Larsson, P., Just, S., Stevens, D., Laurberg, T., Bakland, G., Olsen, I. C. & Van Vollenhoven, R., 2019, In: Arthritis & Rheumatology. 71, S10, 4 p., L09.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  14. Published

    DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

    Grøn, K. L., Glintborg, B., Nørgaard, M., Mehnert, F., Østergaard, M., Dreyer, L., Krogh, N. S., Bjørner, J. B. & Hetland, M. L., 2019, In: Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 1391 1 p., SAT0595.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  15. Published

    Hepatobiliary Events in >5000 Patients with Infl ammatory Arthritis Treated with Biosimilar or Originator Etanercept in Routine Care, Results from the Danish Nationwide DANBIO Registry

    Glintborg, B., Georgiadis, S., Nørgaard, M., Mehnert, F., Grøn, K. L., Krogh, N. S. & Hetland, M. L., 2019, In: Arthritis & Rheumatology. 71, S10, 3 p., 2406.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  16. Published
  17. Published

    OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB. AN OBSERVATIONAL COHORT STUDY

    Grøn, K. L., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S. & Hetland, M. L., 2019, In: Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 630 1 p., THU0667.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  18. Published

    RISK OF HOSPITALIZED INFECTION IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS TREATED WITH BIOLOGICAL DRUGS – A MATCHED COHORT STUDY

    Krabbe, S., Grøn, K. L., Glintborg, B., Mehnert, F., Jarbøl, D. E., Østergaard, M. & Hetland, M. L., 2019, In: Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 214 1 p., OP0266.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  19. 2018
  20. Published

    Rheumatoid Arthritis Patients Treated with Abatacept, Rituximab and Tocilizumab in Denmark and Sweden: Risk of Serious Infections

    Grøn, K. L., Arkema, E. V., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Hetland, M. L., 2018, In: Arthritis & Rheumatology. 70, S9, 2 p., 227.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  21. Published

    Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Hetland, M. L., 2018, In: Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 208 1 p., OP0324.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  22. 2017
  23. Published

    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

    Glintborg, B., Sørensen, I. J., Loft, A. G., Lindegaard, H., Linauskas, A., Hendricks, O., Hansen, I. M. J., Jensen, D. V., Manilo, N., Espesen, J., Klarlund, M., Grydehøj, J., Dieperink, S. S., Kristensen, S., Olsen, J. S., Nordin, H., Chrysidis, S., Dalsgaard Pedersen, D., Sørensen, M. V., Andersen, L. S., Grøn, K. L., Krogh, N. S., Pedersen, L., Hetland, M. L. & all departments of rheumatology in Denmark, Aug 2017, In: Annals of the Rheumatic Diseases. 76, 8, p. 1426-1431 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Baseline Characteristics and Rates of Hospitalized Infections in Patients with Rheumatoid Arthritis Treated with Non-TNF Inhibitors in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, B., Askling, J. & Hetland, M. L., 2017, In: Arthritis & Rheumatology. 69, S10, 134.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  25. Published

    Mandatory choice of first bDMARD in Denmark – an opportunity to study real-life effectiveness? Results from the Danbio registry

    Grøn, K. L., Glintborg, B., Nørgaard, M., Mehnert, F., Østergaard, M., Dreyer, L., Krogh, N. S. & Hetland, M. L., 2017, In: Annals of the Rheumatic Diseases. 76, Suppl 2, p. 451 1 p., THU0649.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  26. 2016
  27. Published

    Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Jensen Hansen, I. M., Bolstad, N., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Warren, D., Goll, G., Gehin, J., Johansen, J. S. & Hetland, M. L., 2016, In: Annals of the Rheumatic Diseases. 75, Suppl. 2, p. 224 1 p., THU0123.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  28. Published

    Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Bolstad, N., Warren, D. J., Gehin, J., Goll, G., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Johansen, J. S. & Hetland, M. L., 2016, In: Scandinavian Journal of Rheumatology. 45, Suppl. 128, p. 6-7 2 p., OP10.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  29. Published

    Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Lindegaard, H., Nordin, H., Bolstad, N., Warren, D., Warren, D., Gehin, J., Goll, G. L., Grøn, K. L., Eng, G. P., Enevold, C., Nielsen, C. H., Johansen, J. S. & Hetland, M. L., 2016, In: Arthritis & Rheumatology. 68, S10, 1997.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  30. 2014
  31. Published

    The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program

    Grøn, K. L., Ørnbjerg, L. M., Hetland, M. L., Aslam, F., Khan, N. A., Jacobs, J. W. G., Henrohn, D., Rasker, J. J., Kauppi, M. J., Lang, H-C., Mota, L. M. H., Aggarwal, A., Yamanaka, H., Badsha, H., Gossec, L., Cutolo, M., Ferraccioli, G., Gremese, E., Bong Lee, E., Inanc, N., Direskeneli, H., Taylor, P., Huisman, M., Alten, R., Pohl, C., Oyoo, O., Stropuviene, S., Drosos, A. A., Kerzberg, E., Ancuta, C., Mofti, A., Bergman, M., Detert, J., Selim, Z. I., Abda, E. A., Rexhepi, B. & Sokka, T., 21 Oct 2014, In: Clinical and Experimental Rheumatology. 32, 6, p. 869-77 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 45084680